Perinatal transmission of hepatitis B virus infection and vaccination in China
View abstract on PubMed
Summary
This summary is machine-generated.Hepatitis B virus (HBV) infection remains a significant health issue in China, with high carrier rates observed. Childhood vaccination shows promise in reducing hepatitis B surface antigen (HBsAg) positivity in younger populations.
Area Of Science
- Hepatology
- Infectious Diseases
- Public Health
Background
- Hepatitis B virus (HBV) infection is a major public health concern in China.
- Historically high infection and carrier rates, particularly among children, have been documented.
- Despite no significant change in overall rates recently, localized vaccination efforts show positive impacts.
Purpose Of The Study
- To review the epidemiology of Hepatitis B virus (HBV) infection in China.
- To assess the impact of vaccination programs on HBV prevalence.
- To highlight the risks associated with childhood HBV infection and long-term sequelae.
Main Methods
- Analysis of historical and recent epidemiological data on HBV infection and HBsAg carrier rates in China.
- Review of vaccination strategies and their observed effects on HBsAg positivity in different age groups.
- Examination of transmission routes, including perinatal and horizontal transmission.
Main Results
- In 1980, HBV infection and HBsAg carrier rates were 42.6% and 10.3% respectively.
- HBsAg positivity in children under 1 year was 5.1-7%, peaking at 24% in 7-14 year olds in Guangdong.
- Areas with universal neonatal HBV vaccination show declining HBsAg positivity in younger demographics.
- Perinatal transmission accounts for 35-50% of carriers, with horizontal transmission also significant.
Conclusions
- Childhood HBV infection increases the risk of long-term complications like hepatocellular carcinoma (HCC).
- Universal childhood immunization is crucial for controlling HBV infections in China.
- Effective vaccination programs are expected to reduce HBV burden over generations.